Evidence map›Paper›PMID 40727541›Full record

ArticleUrology case reports2025

A case report of primary large cell neuroendocrine carcinoma of the urinary bladder.

Yuan Liu, Qi Wang

Abstract readCase Reports
In one paragraph

Article in Urology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yuan LiuDepartment of Radiology, Zhongshan City People's Hospital, Zhongshan 528404, China.
Qi WangDepartment of Urology, Zhongshan City People's Hospital, Zhongshan 528404, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroendocrine carcinoma (NEC) is a highly malignant tumor that originates from neuroendocrine cells, most commonly found in the gastrointestinal tract and lungs. Primary neuroendocrine carcinoma of the bladder is rare, accounting for only 1 % of malignant bladder tumors, with the majority being small cell neuroendocrine carcinoma. Primary large cell neuroendocrine carcinoma (LCNEC) of the bladder is extremely rare. This report presents a case of primary large cell neuroendocrine carcinoma of the bladder treated in the Department of Urology, Zhongshan People's Hospital, in February 2024.

Identifiers

PMID40727541
PMCPMC12301809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.